Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 16;20(1):367.
doi: 10.1186/s12967-022-03532-2.

Clinical features, molecular pathology, and immune microenvironmental characteristics of acral melanoma

Affiliations
Review

Clinical features, molecular pathology, and immune microenvironmental characteristics of acral melanoma

Jianping Gui et al. J Transl Med. .

Abstract

Acral melanoma (AM) has unique biology as an aggressive subtype of melanoma. It is a common subtype of melanoma in races with darker skin tones usually diagnosed at a later stage, thereby presenting a worse prognosis compared to cutaneous melanoma. The pathogenesis of acral melanoma differs from cutaneous melanoma, and trauma promotes its development. Compared to cutaneous melanomas, acral melanomas have a significantly lighter mutational burden with more copy number variants. Most acral melanomas are classified as triple wild-type. In contrast to cutaneous melanomas, acral melanomas have a suppressive immune microenvironment. Herein, we reviewed the clinical features, genetic variants, and immune microenvironmental characteristics of limbic melanomas to summarise their unique features.

Keywords: Acral melanoma; Clinical features; Immune microenvironment; Molecular pathology.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest that are directly relevant to the content of this article.

Figures

Fig. 1
Fig. 1
A summary of the main points in the text. CSVs chromosomal structural variations, CNVs copy number variations, TWT triple wild-type, TILs tumor infiltrating lymphocytes, CTCs circulating tumor cells, CMCs circulating melanoma cells, MCAM melanoma cell adhesion molecule, CR complete response, PR partial remission, SD stable disease, PD progression disease

Similar articles

Cited by

References

    1. Basurto-Lozada P, Molina-Aguilar C, Castaneda-Garcia C, et al. Acral lentiginous melanoma: Basic facts, biological characteristics and research perspectives of an understudied disease. Pigment Cell Melanoma Res. 2021;34(1):59–71. doi: 10.1111/pcmr.12885. - DOI - PMC - PubMed
    1. Rawson RV, Johansson PA, Hayward NK, et al. Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas. Lab Invest. 2017;97(2):130–145. doi: 10.1038/labinvest.2016.143. - DOI - PubMed
    1. Kaskel P, Kind P, Sander S, et al. Trauma and melanoma formation: a true association? Br J Dermatol. 2000;143(4):749–753. doi: 10.1046/j.1365-2133.2000.03770.x. - DOI - PubMed
    1. Huang K, Fan J, Misra S. Acral lentiginous melanoma: incidence and survival in the United States, 2006–2015, an analysis of the SEER Registry. J Surg Res. 2020;251:329–339. doi: 10.1016/j.jss.2020.02.010. - DOI - PubMed
    1. Teramoto Y, Keim U, Gesierich A, et al. Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients. Br J Dermatol. 2018;178(2):443–51. doi: 10.1111/bjd.15803. - DOI - PubMed